119 related articles for article (PubMed ID: 6108573)
1. Increase of plasma ACTH in the rat following the administration of D-met2-pro5-enkephalinamide.
Reina RA; Costa G; Scoto GM; Spadaro C; Spampinato S; Ferri S
Pharmacol Res Commun; 1980 May; 12(5):479-82. PubMed ID: 6108573
[No Abstract] [Full Text] [Related]
2. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
Jhamandas K; Sutak M
Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
[TBL] [Abstract][Full Text] [Related]
3. The in vitro pharmacology of D-Met2,Pro5-enkephalinamide.
Rónai AZ; Berzétei IP; Bajusz S; Székely JI
J Pharm Pharmacol; 1981 Aug; 33(8):534-5. PubMed ID: 6115930
[No Abstract] [Full Text] [Related]
4. (D-Met2,Pro5)-enkephalinamide-induced blockade of ovulation and its reversal by naloxone in the rat.
Köves K; Marton J; Molnár J; Halász B
Neuroendocrinology; 1981 Feb; 32(2):82-6. PubMed ID: 6782500
[TBL] [Abstract][Full Text] [Related]
5. Biphasic effects of a potent enkephalin analogue (D-Met2,Pro5)-enkephalinamide and morphine on locomotor activity in mice.
Székely JI; Miglécz E; Rónai AZ
Psychopharmacology (Berl); 1980; 71(3):299-301. PubMed ID: 6779336
[TBL] [Abstract][Full Text] [Related]
6. Prolactin and growth hormone releasing activity of [D-Met2, Pro5]-enkephalinamide in the rat after systemic administration.
Locatelli V; Cocchi D; Bajusz S; Spampinato S; Müller EE
Experientia; 1978 Dec; 34(12):1650-1. PubMed ID: 729748
[TBL] [Abstract][Full Text] [Related]
7. Effect of Met-enkephalin and (D-Met2,Pro5)-enkephalinamide on the adenylate cyclase activity of rat brain.
Wollemann M; Szebeni A; Bajusz S; Gráf L
Neurochem Res; 1979 Oct; 4(5):627-31. PubMed ID: 492449
[TBL] [Abstract][Full Text] [Related]
8. Morphine and [D-Met2,Pro5]enkephalinamide do not show specific neuroleptic activity.
Sineger E; Horváth K; Miglécz E; Tarnawa I; Andrási F; Székely JI
Eur J Pharmacol; 1982 Jun; 80(4):359-68. PubMed ID: 6125401
[TBL] [Abstract][Full Text] [Related]
9. Comparison of tolerance development and dependence capacities of morphine, beta-endorphin, and [D-Met2, Pro5]-enkephalinamide.
Miglécz E; Székely JI; Dunai-Kovács Z
Psychopharmacology (Berl); 1979 Mar; 62(1):29-34. PubMed ID: 108745
[TBL] [Abstract][Full Text] [Related]
10. In vitro effects of a synethetic enkephalin analogue (D-Met2,Pro5)-enkephalinamide on the hypothalamus-pituitary--testis function in rats.
Vermes I; Szontágh L; Telegdy G
Neurosci Lett; 1979 Feb; 11(2):201-4. PubMed ID: 379712
[TBL] [Abstract][Full Text] [Related]
11. Reward produced by microinjection of (D-Ala2),Met5-enkephalinamide into the ventral tegmental area.
Phillips AG; LePiane FG
Behav Brain Res; 1982 Jun; 5(2):225-9. PubMed ID: 7104089
[No Abstract] [Full Text] [Related]
12. Effect of D-Ala2-met-enkephalinamide and morphine on the activity of choline acetyltransferase and acetylcholinesterase in rat brain.
Herman ZS; Kowalski J
Acta Physiol Pol; 1981; 32(3):233-7. PubMed ID: 7304195
[TBL] [Abstract][Full Text] [Related]
13. [Monoaminergic modulation of the analgesia induced in rats by (D-Ala2)-met-enkephalinamide (DADA)].
Garzón J; Moratalla R; del Río J
Arch Farmacol Toxicol; 1979 Dec; 5(3):177-9. PubMed ID: 546335
[No Abstract] [Full Text] [Related]
14. Stimulation of pulmonary J receptors by an enkephalin-analog.
Sapru HN; Willette RN; Krieger AJ
J Pharmacol Exp Ther; 1981 Apr; 217(1):228-34. PubMed ID: 7205657
[TBL] [Abstract][Full Text] [Related]
15. Central neuropharmacology of D-Ala2-Met-enkephalinamide and its interactions with taurine in rats.
Izumi K; Munekata E; Yamamoto H; Yoshida M; Nakanishi T; Wong P; Barbeau A
Adv Exp Med Biol; 1981; 139():325-43. PubMed ID: 7199249
[No Abstract] [Full Text] [Related]
16. Effects of (D-alanine2, methionine5) enkephalinamide on the release of acetylcholine and noradrenaline from brain slices and isolated nerve terminals.
Jones CA; Marchbanks RM
Biochem Pharmacol; 1982 Feb; 31(3):455-8. PubMed ID: 7073771
[No Abstract] [Full Text] [Related]
17. Central peptidergic stimulation in blood pressure control: role of enkephalins in rats.
Yukimura T; Unger T; Rascher W; Lang RE; Ganten D
Clin Sci (Lond); 1981 Dec; 61 Suppl 7():347s-350s. PubMed ID: 7318336
[No Abstract] [Full Text] [Related]
18. Noradrenergic terminal excitability: effects of opioids.
Nakamura S; Tepper JM; Young SJ; Ling N; Groves PM
Neurosci Lett; 1982 May; 30(1):57-62. PubMed ID: 6124916
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the respiratory activity of (D-Ala2)methionine-enkephalinamide.
Zobrist RH; Allerton HW; Isom GE
Eur J Pharmacol; 1981 Mar; 70(2):121-8. PubMed ID: 6790294
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of four 11C-labelled enkephalin peptides in the brain, pituitary and plasma of rhesus monkeys.
Hartvig P; Någren K; Lundberg PO; Muhr C; Terenius L; Lundqvist H; Lärkfors L; Långström B
Regul Pept; 1986 Dec; 16(1):1-13. PubMed ID: 3492729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
